Journal article
The ability to form primary tumor xenografts is predictive of increased risk of disease recurrence in early-stage non-small cell lung cancer
T John, D Kohler, M Pintilie, N Yanagawa, NA Pham, M Li, D Panchal, F Hui, F Meng, FA Shepherd, MS Tsao
Clinical Cancer Research | Published : 2011
Abstract
Purpose: Primary tumor xenografts (PTXG) established directly from patients' primary tumors in immunosuppressed animals might represent the spectrum of histologic complexity of lung cancers better than xenografts derived from established cell lines. These models are important in the study of aberrant biological pathways in cancers and as preclinical models for testing new therapeutic agents. However, not all primary tumors engraft when implanted into immunosuppressed mice. We have investigated factors that may influence the ability of primary non-small cell lung cancer (NSCLC) to form xenografts and their association with clinical outcome. Experimental Design: Tumor fragments from patients u..
View full abstractGrants
Awarded by Terry Fox Foundation STIHR at CIHR
Funding Acknowledgements
This work was supported by International Association for the Study of Lung Cancer Young Investigator Award (T. John), Ontario Premier's Summit Award (F. A. Shepherd), Ontario Ministry of Research and Innovation, Ontario Institute of Cancer Research, and the Terry Fox Foundation STIHR at CIHR grant TGT-53912 (D. Kohler, N. Yanagawa).